首页> 外文期刊>Journal of Translational Medicine >Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
【24h】

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma

机译:Galectin-3与原发性肝细胞癌预后不良有关

获取原文
           

摘要

Background Galectin-3, a member of the beta-galactoside-binding lectin family, is a multifunctional protein with various biological functions, including the proliferation and differentiation of tumor cells, angiogenesis, cancer progression, and metastasis. We aimed to clarify if expression of galectin-3 is related to the clinicopathological characteristics and prognosis of hepatocellular carcinoma (HCC) patients, and to explore the possible mechanisms of galectin-3 in hepatocellular carcinoma. Methods First, we investigated galectin-3 mRNA and protein expression by using RT-PCR and Western blotting. Second, tissues from 165 HCC patients were used to evaluate clinicopathological characteristics and prognosis through immunohistochemical analyses. Furthermore, the functions of galectin-3 were analyzed with respect to the proliferation, cell cycle,apoptosis, migration, and invasion of HCC cell lines. Finally, we analyzed galectin-3 expression and micro-vessel density (MVD) by immunohistochemistry (IHC) to find its correlation with angiogenesis in Hepatocellular Carcinoma. Flow cytometer was used to explore apoptosis and Western-blot was used to detect the pathway proteins of apoptosis. Results Galectin-3 showed high expression at the mRNA and protein levels in HCC cancer tissues and cell lines. Clinicopathological analyses revealed that increased expression of galectin-3 in tumors was closely associated with a poor prognosis. Galectin-3 knockdown by siRNA significantly inhibited cell growth, migration, and invasion, and induced apoptosis in HCC cells in vitro, whereas galectin-3 overexpression promoted cell growth, migration, and invasion. Correlation analysis of galectin-3 expression and micro-vessel density (MVD) showed that galectin-3 expression in tumor cells stimulates angiogenesis. The observed regulation of cell apoptosis was accompanied by the galectin-3-mediated modulation of caspase3 signaling pathways in HCC cells. Conclusions These data suggest that galectin-3 plays an important part in HCC progression and may serve as a prognostic factor for HCC.
机译:背景Galectin-3是β-半乳糖苷结合凝集素家族的成员,是一种具有多种生物学功能的多功能蛋白,包括肿瘤细胞的增殖和分化,血管生成,癌症进展和转移。我们旨在弄清galectin-3的表达是否与肝细胞癌(HCC)患者的临床病理特征和预后有关,并探讨galectin-3在肝细胞癌中的可能机制。方法首先,我们通过RT-PCR和Western blotting研究galectin-3 mRNA和蛋白的表达。其次,通过免疫组织化学分析,将165例HCC患者的组织用于评估临床病理特征和预后。此外,针对肝癌细胞系的增殖,细胞周期,凋亡,迁移和侵袭,分析了galectin-3的功能。最后,我们通过免疫组织化学(IHC)分析了galectin-3的表达和微血管密度(MVD),以发现其与肝细胞癌血管生成的相关性。流式细胞仪检测细胞凋亡,Western-blot检测细胞凋亡的途径蛋白。结果Galectin-3在HCC癌组织和细胞系中的mRNA和蛋白水平高表达。临床病理分析表明,galectin-3在肿瘤中的表达增加与不良预后密切相关。 siRNA对Galectin-3的抑制作用在体外显着抑制了细胞的生长,迁移和侵袭,并诱导了HCC细胞凋亡,而galectin-3的过表达促进了细胞的生长,迁移和侵袭。 galectin-3表达与微血管密度(MVD)的相关分析表明,galectin-3在肿瘤细胞中的表达可刺激血管生成。观察到的细胞凋亡调节伴随着半乳凝素3介导的HCC细胞中caspase3信号通路的调节。结论这些数据表明,galectin-3在肝癌的进展中起着重要的作用,并可能作为肝癌的预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号